News Sentiment

2592 sentiment intelligence

Cloudbreak Pharma Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 47 Balanced news tone 9 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.34 Week of 10 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 9

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+3.9% over one week, +3.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Cloudbreak Pharma Wins FDA Safety Clearance to Begin CBT-358 Clinical Investigation

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction 3.9% Price confirming higher
Trend fit Trend inactive 3.1% over four weeks
Fair value -62.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 8
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 9
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GlobeNewswire 3
TipRanks 2
TradingView 1
ARC Group 1
simplywall.st 1
hkex.com.hk 1

Event Lens

What the news is about

Classified themes
Market update 6
Regulatory and legal 1
Earnings 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-9 of 9